Pharmedic Pharmaceutical Medicinal JSC (HNX:PMC)

Vietnam flag Vietnam · Delayed Price · Currency is VND
130,000
-4,900 (-3.63%)
At close: Jun 5, 2026
Market Cap1.21T +14.8%
Revenue (ttm)559.51B +7.1%
Net Income60.31B -6.4%
EPS6,456.00 -1.2%
Shares Out 9.33M
PE Ratio20.14
Forward PEn/a
Dividend2,400.00 (1.85%)
Ex-Dividend DateApr 21, 2026
Volume2,210
Open122,200
Previous Close134,900
Day's Range122,000 - 130,000
52-Week Range100,200 - 189,000
Beta-0.21
Analystsn/a
Price Targetn/a
Earnings DateJul 17, 2026

About HNX:PMC

Pharmedic Pharmaceutical Medicinal Joint Stock Company manufactures and sells pharmaceutical products in Vietnam. The company offers over the counter drug products, such as medicines from medicinal herbs; minerals and vitamins; eye, ENT, and cough treatment; disinfectants; anti-allergic drugs; gastrointestinal and hepatobiliary drugs; external medications; drugs to treat parasites and bacterial infections analgesic, antipyretic, anti-inflammatory, and gout treatment; cardiovascular and diabetes; and psychoactive drugs. It is also involved in th... [Read more]

Industry Pharmaceutical Preparations
Founded 1981
Employees 516
Stock Exchange Hanoi Stock Exchange
Ticker Symbol PMC
Full Company Profile

Financial Performance

In 2025, HNX:PMC's revenue was 546.57 billion, an increase of 9.71% compared to the previous year's 498.18 billion. Earnings were 60.08 billion, an increase of 2.71%.

Financial Statements